rs267608547
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001323289.2(CDKL5):c.904C>T(p.Leu302Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000183 in 1,094,281 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 23)
Exomes 𝑓: 0.0000018 ( 0 hom. 1 hem. )
Consequence
CDKL5
NM_001323289.2 missense
NM_001323289.2 missense
Scores
2
7
8
Clinical Significance
Conservation
PhyloP100: 7.38
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.42176068).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKL5 | NM_001323289.2 | c.904C>T | p.Leu302Phe | missense_variant | 11/18 | ENST00000623535.2 | NP_001310218.1 | |
CDKL5 | NM_001037343.2 | c.904C>T | p.Leu302Phe | missense_variant | 12/22 | NP_001032420.1 | ||
CDKL5 | NM_003159.3 | c.904C>T | p.Leu302Phe | missense_variant | 11/21 | NP_003150.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDKL5 | ENST00000623535.2 | c.904C>T | p.Leu302Phe | missense_variant | 11/18 | 1 | NM_001323289.2 | ENSP00000485244.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183364Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67850
GnomAD3 exomes
AF:
AC:
1
AN:
183364
Hom.:
AF XY:
AC XY:
1
AN XY:
67850
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000183 AC: 2AN: 1094281Hom.: 0 Cov.: 29 AF XY: 0.00000278 AC XY: 1AN XY: 359787
GnomAD4 exome
AF:
AC:
2
AN:
1094281
Hom.:
Cov.:
29
AF XY:
AC XY:
1
AN XY:
359787
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy, 2 Uncertain:1
Uncertain significance, no assertion criteria provided | curation | RettBASE | Mar 13, 2014 | In silico prediction: SIFT = tolerated, MutationTaster = disease-causing, PolyPhen2 = probably damaging, AlignGVGD = benign (C0), no parental screening results - |
CDKL5 disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | curation | Centre for Population Genomics, CPG | Sep 11, 2024 | This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 3.0, this variant is classified as a variant of uncertain significance. The allele frequency of this variant in one population in gnomAD is 0.006%, not meeting the criteria BS1. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.;T;.;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.;M;.;M
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;.;N;.;.
REVEL
Uncertain
Sift
Benign
T;.;.;T;.;.
Sift4G
Benign
T;.;.;T;T;T
Polyphen
D;.;.;D;.;.
Vest4
MutPred
Loss of catalytic residue at L302 (P = 0.0711);Loss of catalytic residue at L302 (P = 0.0711);Loss of catalytic residue at L302 (P = 0.0711);Loss of catalytic residue at L302 (P = 0.0711);Loss of catalytic residue at L302 (P = 0.0711);Loss of catalytic residue at L302 (P = 0.0711);
MVP
MPC
0.48
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at